N,N-dimethyl-N-(2-(((2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-((acetyloxy)methyl)oxan-2-yl)oxy)ethyl)cyclopropylammonium

DB18308ExperimentalSmall molecule

N,N-dimethyl-N-(2-(((2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-((acetyloxy)methyl)oxan-2-yl)oxy)ethyl)cyclopropylammonium: Overview.

Formula / weight: C₂₁H₃₄NO₁₀ · 460.499 g/mol (avg)

Resolves to

Compound

UNIIJ6QN4FZ2UGCAS2440155-89-3

Structure

InChIKeyFOZFSJHFTYNIRJ-YMQHIKHWSA-NSMILESCC(=O)OC[C@H]1O[C@@H](OCC[N+](C)(C)C2CC2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

Which companies are running trials of N,N-dimethyl-N-(2-(((2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-((acetyloxy)methyl)oxan-2-yl)oxy)ethyl)cyclopropylammonium, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account